Myomo, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MYO | LFWD | 1612.HK | MBOT | XTNT | TCMD | |
|---|---|---|---|---|---|---|
| Market cap | 51.49M | 17.16M | 462.07M | 76.57M | 41.53M | 608.87M |
| P/E (TTM) | — | — | 4.7 | — | — | 26.4 |
| Forward P/E | -5.9 | -7.0 | 11.7 | -3.6 | -9.9 | 18.5 |
| Price/book | 8.8 | 1.4 | 0.6 | 1.1 | 1.0 | 2.7 |
| Dividend yield | — | — | 5.63% | — | — | — |
| 1-year change | +59.12% | −5.08% | −16.47% | −48.58% | −62.03% | +13.87% |
| Today | +1.56% | +3.95% | −1.41% | +4.59% | +6.47% | +9.69% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All MYO news ›Myomo to Attend the 17th Annual Craig Hallum Alpha Select Conference
BioSpace Myomo to Attend the 17th Annual Craig Hallum Alpha Select Conference BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increas
Myomo to Report Third Quarter 2026 Financial Results on November 9
BioSpace Myomo to Report Third Quarter 2026 Financial Results on November 9 BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased f
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
“We are excited for Katie to join us as we enter our next phase of growth,” said Paul R. Gudonis, Chairman and Chief Executive Officer of Myomo. "Her experience building commercial teams, expanding market access, and scaling clinical…
Myomo officer David Henry plans 3,133-share sale
To pay taxes only, Myomo (MYO) officer plans to sell 3,133 shares as stock grants vest. Stock Titan Myomo officer David Henry plans 3,133-share sale The planned sale is designated solely for taxes tied to the October 8 restricted stock…
[Form 3] MYOMO, INC. Initial Statement of Beneficial Ownership
Myomo, Inc. (NYSE American: MYO) is a wearable medical robotics company focused on MyoPro myoelectric orthoses that help restore upper-limb function. - [Form 3] MYOMO, INC. Initial Statement of Beneficial Ownership Sentiment and the…
Myomo grants commercial chief 275,000 stock units
Myomo, Inc. (NYSE American: MYO) is a wearable medical robotics company focused on MyoPro myoelectric orthoses that help restore upper-limb function. Myomo grants commercial chief 275,000 stock units The award's vesting schedule runs from…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net4
- biospace.com2
- natlawreview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.